Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,663 | 12,357 | 1,117 | 4,391 | N/A |
| Receivables | 200 | 61 | 31 | 57 | N/A |
| TOTAL | $53,150 | $14,558 | $1,228 | $4,558 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,084 | 2,825 | 3,609 | 5,427 | N/A |
| Other Non-Current Assets | 700 | 700 | 700 | 700 | 0 |
| TOTAL | $2,784 | $3,525 | $4,309 | $6,127 | $N/A |
| Total Assets | $55,934 | $18,083 | $5,537 | $10,685 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 307 | 753 | N/A |
| Accrued Expenses | 1,946 | 1,958 | 906 | 2,176 | N/A |
| TOTAL | $3,398 | $5,433 | $1,686 | $2,929 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,452 | 3,475 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 874 | 1,139 | 3,462 | 1,652 | 0 |
| TOTAL | $874 | $1,139 | $3,462 | $1,652 | $N/A |
| Total Liabilities | $4,272 | $6,572 | $5,148 | $4,581 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 634 | 627 | N/A | N/A | N/A |
| Common Shares | 23 | 4 | 3 | 3 | N/A |
| Retained earnings | -80,201 | -62,456 | -59,384 | -53,113 | N/A |
| Other shareholders' equity | 0 | 65,586 | 58,522 | 58,168 | 0 |
| TOTAL | $51,662 | $11,511 | $389 | $6,104 | $N/A |
| Total Liabilities And Equity | $55,934 | $18,083 | $5,537 | $10,685 | $0 |